These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28656205)

  • 1. Role of PKA in the process of neonatal cardiomyocyte hypertrophy induced by urotensin II.
    Xu J; Han Q; Shi H; Liu W; Chu T; Li H
    Int J Mol Med; 2017 Aug; 40(2):499-504. PubMed ID: 28656205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urotensin II induction of neonatal cardiomyocyte hypertrophy involves the CaMKII/PLN/SERCA 2a signaling pathway.
    Shi H; Han Q; Xu J; Liu W; Chu T; Zhao L
    Gene; 2016 May; 583(1):8-14. PubMed ID: 26930364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor alpha protects heart cultures against hypoxic damage via activation of PKA and phospholamban to prevent calcium overload.
    El-Ani D; Philipchik I; Stav H; Levi M; Zerbib J; Shainberg A
    Can J Physiol Pharmacol; 2014 Nov; 92(11):917-25. PubMed ID: 25349921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II and the JNK pathway mediate urotensin II expression in response to hypoxia in rat cardiomyocytes.
    Chiu CZ; Wang BW; Shyu KG
    J Endocrinol; 2014 Mar; 220(3):233-46. PubMed ID: 24481965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholamban pentamers attenuate PKA-dependent phosphorylation of monomers.
    Wittmann T; Lohse MJ; Schmitt JP
    J Mol Cell Cardiol; 2015 Mar; 80():90-7. PubMed ID: 25562800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation.
    Funk F; Kronenbitter A; Hackert K; Oebbeke M; Klebe G; Barth M; Koch D; Schmitt JP
    Cardiovasc Res; 2023 Jul; 119(7):1568-1582. PubMed ID: 36869774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV alleviates hypoxia/reoxygenation-induced neonatal rat cardiomyocyte injury via the protein kinase a pathway.
    Zhang DW; Bian ZP; Xu JD; Wu HF; Gu CR; Zhou B; Chen XJ; Yang D
    Pharmacology; 2012; 90(1-2):95-101. PubMed ID: 22797566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3beta signaling pathway.
    Gruson D; Ginion A; Decroly N; Lause P; Vanoverschelde JL; Ketelslegers JM; Bertrand L; Thissen JP
    Peptides; 2010 Jul; 31(7):1326-33. PubMed ID: 20416349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy.
    Tzanidis A; Hannan RD; Thomas WG; Onan D; Autelitano DJ; See F; Kelly DJ; Gilbert RE; Krum H
    Circ Res; 2003 Aug; 93(3):246-53. PubMed ID: 12842917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats.
    Zou Y; Nagai R; Yamazaki T
    FEBS Lett; 2001 Nov; 508(1):57-60. PubMed ID: 11707268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
    Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K
    Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between A-kinase anchoring protein 5 and protein kinase A mediates CaMKII/HDAC signaling to inhibit cardiomyocyte hypertrophy after hypoxic reoxygenation.
    Zhang X; Wang Q; Wang Z; Zhang H; Zhu F; Ma J; Wang W; Chen Z; Wang H
    Cell Signal; 2023 Mar; 103():110569. PubMed ID: 36565899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.
    Wang L; Burmeister BT; Johnson KR; Baillie GS; Karginov AV; Skidgel RA; O'Bryan JP; Carnegie GK
    Cell Signal; 2015 May; 27(5):908-22. PubMed ID: 25683917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholamban degradation is induced by phosphorylation-mediated ubiquitination and inhibited by interaction with cardiac type Sarco(endo)plasmic reticulum Ca(2+)-ATPase.
    Nakagawa T; Yokoe S; Asahi M
    Biochem Biophys Res Commun; 2016 Apr; 472(3):523-30. PubMed ID: 26966065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TSH inhibits SERCA2a and the PKA/PLN pathway in rat cardiomyocytes.
    Dong J; Gao C; Liu J; Cao Y; Tian L
    Oncotarget; 2016 Jun; 7(26):39207-39215. PubMed ID: 27206677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A-kinase anchoring protein 5 anchors protein kinase A to mediate PLN/SERCA to reduce cardiomyocyte apoptosis induced by hypoxia and reoxygenation.
    Wang Z; Zhang X; Zhu F; Zhou S; Wang Q; Wang H
    Biochem Cell Biol; 2022 Apr; 100(2):162-170. PubMed ID: 35041539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urotensin II induces hypertrophy of in vitro cultured neonatal rat cardiac myocytes].
    Zuo HH; Hong JM; Guo HS; Wei JR; He YH; Li ZL
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jun; 24(6):642-5. PubMed ID: 15201078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urotensin II induces activation of NLRP3 and pyroptosis through calcineurin in cardiomyocytes.
    Liang Y; Wu X; Xu M; Ding L; Li H; Wu Y
    Peptides; 2021 Oct; 144():170609. PubMed ID: 34242679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of stachydrine on norepinephrine-induced neonatal rat cardiac myocytes hypertrophy and intracellular calcium transients.
    Zhang C; Shan XL; Liao YL; Zhao P; Guo W; Wei HC; Lu R
    BMC Complement Altern Med; 2014 Dec; 14():474. PubMed ID: 25488774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGR5 activation ameliorates hyperglycemia-induced cardiac hypertrophy in H9c2 cells.
    Cheng KC; Chang WT; Kuo FY; Chen ZC; Li Y; Cheng JT
    Sci Rep; 2019 Mar; 9(1):3633. PubMed ID: 30842472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.